Theravance Biopharma, Inc.
TBPH
$9.75
$0.212.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.30% | -4.91% | -3.90% | -2.39% | -23.56% |
| Total Receivables | 306.29% | 17.81% | -2.49% | -16.08% | 2.44% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -48.31% | -7.35% | -7.51% | -29.22% | 28.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 38.28% | -2.37% | -4.01% | -6.92% | -17.41% |
|
|
|||||
| Total Current Assets | 38.28% | -2.37% | -4.01% | -6.92% | -17.41% |
| Net Property, Plant & Equipment | -3.64% | -7.10% | -9.36% | -2.81% | -3.22% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.31% | -0.13% | -0.08% | -0.08% | -0.94% |
| Total Assets | -0.55% | -1.64% | -2.50% | -2.80% | -7.64% |
|
|
|||||
| Total Accounts Payable | 54.20% | -13.14% | -0.71% | 10.63% | -35.64% |
| Total Accrued Expenses | 17.56% | 6.93% | 12.10% | -26.55% | -3.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 155.29% | -0.55% | 3.84% | 3.57% | -59.61% |
| Total Finance Division Other Current Liabilities | -9.82% | 0.00% | 0.00% | 0.00% | 26,941.67% |
| Total Other Current Liabilities | -9.82% | 0.00% | 0.00% | 0.00% | 26,941.67% |
| Total Current Liabilities | 36.91% | 2.13% | 5.93% | -12.54% | -2.37% |
|
|
|||||
| Total Current Liabilities | 36.91% | 2.13% | 5.93% | -12.54% | -2.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.11% | -3.90% | -3.19% | -3.09% | 10.02% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.12% | 3.18% | 2.00% | 1.96% | -1.95% |
| Total Liabilities | 4.79% | 1.25% | 1.14% | -1.52% | 0.92% |
|
|
|||||
| Common Stock & APIC | 0.48% | 0.41% | 0.47% | 0.31% | -2.16% |
| Retained Earnings | -1.63% | -1.35% | -1.80% | -1.28% | -0.94% |
| Treasury Stock & Other | -86.00% | 327.27% | 46.34% | 36.92% | 71.11% |
| Total Common Equity | -5.45% | -4.15% | -5.46% | -3.82% | -13.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.45% | -4.15% | -5.46% | -3.82% | -13.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.45% | -4.15% | -5.46% | -3.82% | -13.46% |
|
|
|||||